Rabat – Lalla Salma Foundation’s cancer screening campaigns have revealed that the rate of diagnosed metastatic cancers (cancers that develop secondary malignant tumors at a distance from the primary site of cancer) decreased to less than 7% in 2017.
The rate of metastatic cancers subsided to less than 7%, in comparison with 60% in 1997, said Hassan Errihani, president of the Moroccan Association of Training and Research in Medical Oncology (AMFROM) on the sidelines of the 8th National Congress of Medical Oncology which began Friday in Rabat.
He added that this decline reflects the “positive” impact of early diagnosis through screening and awareness campaigns conducted by the Lalla Salma Foundation in partnership with the Ministry of Health in all regions of the Kingdom.
The event, which was organized by AMFROM in partnership with the Lalla Salma Foundation’s sector of the prevention and treatment of cancers and the African School of Oncology (EAO), aims to promote continuing medical education in medical oncology.
It also aims to federate all the medical oncologists distributed throughout the territory and to allow exchanges with other specialists taking care of this disease.
